Life Sciences News | BioTuesdays by Kilmer Lucas IR

Executive Moves

Lake Street Captial Markets names Alex Nowak as director investment banking

Alex Nowak has joined Lake Street Capital Markets’ growing banking team as director of the healthcare investment banking practice. In his new role, Mr. Nowak will focus on expanding client relationships and supporting...

October 15, 2024

Executive Moves

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

Ladenburg Thalmann has announced the appointment of Murat Omur as managing director in the healthcare investment banking division. With 17 years of investment banking experience in healthcare and the M&A sector, Mr...

October 15, 2024

Developments

Ripple and Glaukos ink evaluation and licensing agreements

Closely-held Ripple Therapeutics has announced evaluation and licensing agreements with Glaukos Corporation (NYSE:GKOS), enabling Glaukos to leverage Ripple’s proprietary technology platform to create sustained release...

October 15, 2024

Developments

Conavi completes go-public transaction

Conavi Medical has completed its reverse takeover of Titan Medical (TSX:TMD; OTC:TMDIF). The combined company (the Resulting Issuer), which will voluntarily delist from the TSX on or about October 15, 2024, and...

October 11, 2024

Developments

Aurinia presents new real-world data reinforcing LUPKYNIS in LN at ASN Kidney Week 2024

Aurinia Pharmaceuticals (NASDAQ:AUPH) has announced plans to present new data reinforcing the clinical significance of LUPKYNIS in the treatment of lupus nephritis (LN) at the American Society of Nephrology (ASN) Kidney...

October 11, 2024

Developments

Turnstone restructures to focus resources on advancing Phase 1 study

Turnstone Biologics (NASDAQ:TSBX) has announced restructuring initiatives that include the strategic prioritization of its pipeline, a 60% workforce reduction, and changes to its leadership team, aimed at focusing...

October 11, 2024

Executive Moves

MaxCyte appoints Ali Soleymannezhad as CCO

MaxCyte (NASDAQ:MXCT; LSE:MXCT) has appointed Ali Soleymannezhad as chief commercial officer, effective September 11, 2024. Prior to this role, Mr. Soleymannezhad served as executive vice president of bioprocessing at...

October 10, 2024

Developments

Health Canada clears Palisade to commence Phase 1 study of PALI-2108 in UC

Palisade Bio (NASDAQ:PALI) has announced that it has received a No Objection Letter from Health Canada for its Phase 1 clinical trial of PALI-2108 for the treatment of ulcerative colitis (UC). The orally-administered...

October 10, 2024

Developments

Clearmind receives IRB approval for trial of CMND-100 for AUD at second clinical site

Clearmind Medicine (NASDAQ:CMND) has announced that it has received Institutional Review Board (IRB) approval from one of its U.S. clinical sites for part A of its Phase I/IIa clinical trial of CMND-100 for the...

October 10, 2024

Developments

SI-BONE reports first in-patient procedures with TNT implant system for pelvic fractures

SI-BONE (NASDAQ:SIBN) has announced the first in-patient procedures using its iFuse TORQ TNT Implant System (TNT), designed to address anatomic and biomedical challenges of pelvic fragility fractures as opposed to...

October 10, 2024

Developments

Perimeter completes patient enrollment for pivotal trial evaluating next-gen OCT B-Series with ImgAssist AI in breast cancer surgery

Perimeter Medical Imaging AI (TSXV:PINK; OTC:PYNKF) has announced the completion of patient enrollment in a pivotal clinical study evaluating its next-generation Perimeter B-Series OCT system, which combines proprietary...

October 3, 2024

Executive Moves

Eupraxia expands Amanda Malone’s leadership role and names Rahul Sarugaser as EVP, corporate development

Eupraxia Pharmaceuticals (TSX:EPRX; NASDAQ:EPRX) has announced the appointments of Amanda Malone as chief operating and scientific officer and Rahul Sarugaser as executive vice president of corporate development. In her...

October 3, 2024

Lake Street Captial Markets names Alex Nowak as director investment banking

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

Ripple and Glaukos ink evaluation and licensing agreements

Conavi completes go-public transaction

Aurinia presents new real-world data reinforcing LUPKYNIS in LN at ASN Kidney Week 2024

Turnstone restructures to focus resources on advancing Phase 1 study

MaxCyte appoints Ali Soleymannezhad as CCO

Health Canada clears Palisade to commence Phase 1 study of PALI-2108 in UC

Clearmind receives IRB approval for trial of CMND-100 for AUD at second clinical site

SI-BONE reports first in-patient procedures with TNT implant system for pelvic fractures

Perimeter completes patient enrollment for pivotal trial evaluating next-gen OCT B-Series with ImgAssist AI in breast cancer surgery

Eupraxia expands Amanda Malone’s leadership role and names Rahul Sarugaser as EVP, corporate development

General

More